Doramectin
Names
[ CAS No. ]:
117704-25-3
[ Name ]:
Doramectin
[Synonym ]:
Doromectin
extended von Baeyer nomenclature: (10E,14E,16E)-(1R,4S,5’S,6S,6’R,8R,12S,13S,20R,21R,24S)-6’-cyclohexyl-21,24-dihydroxy-5’,11,13,22-tetramethyl-2-oxo-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2’-(5’,6’-dihydro-2’H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
Doramectina
Doramectin
25-cyclohexyl-avermectin B1
DONGGUAI.P.E
bridged fused ring systems nomenclature: (2aE,4E,8E)-(5’S,6S,6’R,7S,11R,13S,15S,17aR,20R,20aR,20bS)-6’-cyclohexyl-5’,6,6’,7,10,11,14,15,17a,20,20a,20b-dodecahydro-20,20b-dihydroxy-5’,6,8,19-tetramethyl-17-oxospiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
Dectoma
Dectomax
25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin A1a
Doramecin
Biological Activity
[Description]:
[Related Catalog]:
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
967.4±65.0 °C at 760 mmHg
[ Melting Point ]:
116 - 119ºC
[ Molecular Formula ]:
C50H74O14
[ Molecular Weight ]:
899.114
[ Flash Point ]:
274.4±27.8 °C
[ Exact Mass ]:
898.507874
[ PSA ]:
170.06000
[ LogP ]:
7.16
[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C
[ Index of Refraction ]:
1.580
[ Storage condition ]:
0-6°C
[ Water Solubility ]:
methanol: soluble
MSDS
Safety Information
[ Symbol ]:
GHS06, GHS09
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H301-H410
[ Precautionary Statements ]:
P273-P301 + P310-P501
[ Personal Protective Equipment ]:
Eyeshields;Faceshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
T,N,Xi
[ Risk Phrases ]:
R25
[ Safety Phrases ]:
33-45-60-61-36/37-26
[ RIDADR ]:
UN 2811 6.1/PG 3
Articles
Can. Vet. J. 53(12) , 1310-3, (2012)
A herd of alpacas was examined because of a history of severe endoparasitism, anemia, hypoproteinemia, and weight loss. Resistance of gastrointestinal nematodes to albendazole, fenbendazole, and doram...
Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.J. Pharm. Pharmacol. 62(3) , 393-9, (2010)
Multidrug resistance (MDR) is a serious obstacle encountered in cancer treatment. This study was performed to explore the reversal of MDR by doramectin from the avermectin family and nemadectin belong...
The influence of gastrointestinal parasitism on fecal elimination of doramectin, in lambs.Ecotoxicol. Environ. Saf. 73(8) , 2017-21, (2010)
A study was done to investigate the effect of parasitism on patterns of doramectin (DRM) fecal elimination in lambs. Fourteen Suffolk Down parasitized lambs (26.9 ± 1.5 kg body weight: bw) were purpos...